Related Experiment Videos
Evaluation of population (NONMEM) pharmacokinetic parameter estimates
S Vozeh1, P O Maitre, D R Stanski
1Department of Medicine, University Hospital, Kantonsspital Basel, Switzerland.
Journal of Pharmacokinetics and Biopharmaceutics
|April 1, 1990
Summary
Population pharmacokinetic analysis requires independent evaluation of results from observational studies. This report details a method for assessing parameter estimates, ensuring reliability in pharmacokinetic modeling.
Area of Science:
- Pharmacokinetics
- Pharmacometric modeling
- Drug development
Background:
- Population pharmacokinetic (Pop-PK) analysis is increasingly utilized in drug development.
- Reliability of Pop-PK results from observational studies requires independent validation.
- Existing methods for evaluating Pop-PK parameter estimates can be complex.
Purpose of the Study:
- To highlight the necessity of independent evaluation for Pop-PK analysis results.
- To present a general method for evaluating parameter estimates from observational data.
- To advocate for integrated software solutions for reliability assessment in Pop-PK.
Main Methods:
- A specific example using Alfentanil and the NONMEM software system is presented.
- A regression-based method is described to test for bias in fixed and random effects.
- The method is designed to be independent of the number of observations per patient and dosing.
Main Results:
- A general method for evaluating Pop-PK parameter estimates from observational data is described.
- The method allows for bias testing in fixed and random effects, irrespective of data structure.
- The evaluation procedure for concentration prediction bias can be complex.
Conclusions:
- Independent evaluation of Pop-PK analysis results is crucial for investigators.
- Software packages for Pop-PK estimation should include tools for reliability assessment.
- Implementing robust evaluation methods enhances the trustworthiness of pharmacokinetic parameter estimates.